---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-141187"
form_type: "8-K"
ticker: "GRTX"
cik: "0001563577"
company_name: "Galera Therapeutics, Inc."
filed_at: "2026-04-03T23:59:59+00:00"
generated_at: "2026-05-15T07:35:45.616224+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Galera Therapeutics schedules 2025/2026 Annual Meeting for May 8, 2026

## Summary
- Stockholder proposal/nomination deadline set for April 13, 2026.
- Meeting date is more than 60 days after 2024 Annual Meeting; new deadlines apply.
- Universal proxy rule (Rule 14a-19) notice also due by April 13, 2026.
- Proposals for inclusion in proxy materials must be received by April 13, 2026.

## SEC filing metadata
- accession: 0001193125-26-141187
- form_type: 8-K
- ticker: GRTX
- cik: 0001563577
- company_name: Galera Therapeutics, Inc.
- filed_at: 2026-04-03T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1563577/000119312526141187/0001193125-26-141187-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1563577/000119312526141187/d117348d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-141187
- JSON: https://secwatch.observer/filing/0001193125-26-141187.json
- Plain text: https://secwatch.observer/filing/0001193125-26-141187.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.